MARKET

CSII

CSII

Cardiovascular
NASDAQ

Real-time Quotes | Nasdaq Last Sale

43.87
-0.31
-0.70%
Closed 17:04 12/05 EST
OPEN
44.26
PREV CLOSE
44.18
HIGH
44.57
LOW
43.67
VOLUME
115.32K
TURNOVER
--
52 WEEK HIGH
52.54
52 WEEK LOW
24.84
MARKET CAP
1.54B
P/E (TTM)
-471.2137
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CSII and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CSII News

  • Edited Transcript of CSII earnings conference call or presentation 29-Oct-19 8:30pm GMT
  • Thomson Reuters StreetEvents.3d ago
  • Cardiovascular Systems (CSII) Up 6.2% Since Last Earnings Report: Can It Continue?
  • Zacks.11/28 14:31
  • Cardiovascular Systems (CSII) Presents At Stifel Healthcare Conference - Slideshow
  • Seeking Alpha - Article.11/20 17:07
  • Cardiovascular Systems, Inc. Announces Stephen Stenbeck Joins Board of Directors
  • Business Wire.11/12 22:00

More

Industry

Medical Equipment, Supplies & Distribution
-0.05%
Healthcare Equipment & Supplies
-0.01%

Hot Stocks

Name
Price
%Change

About CSII

Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications. Its peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee. Its products include Diamondback 360 Peripheral Orbital Atherectomy System (OAS) (Diamondback 360 Peripheral), the Stealth 360 OAS (Stealth 360), Diamondback 360 Peripheral, Diamondback 360 60cm Peripheral, Diamondback 360 Low Profile Peripheral, Diamondback 360 1.50 Peripheral and Diamondback 360 2.00 Peripheral. The Company's coronary arterial disease (CAD) product, Diamondback 360 Coronary OAS (Coronary OAS), is marketed as a treatment for severely calcified coronary arteries.
More

Webull offers Cardiovascular Systems Inc (CSII) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.